{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:22:34Z","timestamp":1792113754958,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology Major Project of Hunan Province","award":["2017SK1020"],"award-info":[{"award-number":["2017SK1020"]}]},{"name":"National Key R&D Program of China","award":["2018YFC1315603"],"award-info":[{"award-number":["2018YFC1315603"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108007"],"award-info":[{"award-number":["81820108007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00592-020-01591-9","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T04:44:51Z","timestamp":1597898691000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus"],"prefix":"10.1007","volume":"58","author":[{"given":"Shan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-6231","authenticated-orcid":false,"given":"Gan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"issue":"2","key":"1591_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2337\/db12-0207","volume":"62","author":"Z Zhou","year":"2013","unstructured":"Zhou Z, Xiang Y, Ji L et al (2013) Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study. Diabetes 62(2):543\u2013550. https:\/\/doi.org\/10.2337\/db12-0207","journal-title":"Diabetes"},{"issue":"1\u20132","key":"1591_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cca.2008.12.038","volume":"402","author":"T Du","year":"2009","unstructured":"Du T, Zhou ZG, You S et al (2009) Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta 402(1\u20132):133\u2013138. https:\/\/doi.org\/10.1016\/j.cca.2008.12.038","journal-title":"Clin Chim Acta"},{"issue":"2","key":"1591_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12016-014-8422-2","volume":"47","author":"Z Xie","year":"2014","unstructured":"Xie Z, Chang C, Zhou Z (2014) Molecular mechanisms in autoimmune type 1 diabetes: a critical review. Clin Rev Allergy Immunol 47(2):174\u2013192. https:\/\/doi.org\/10.1007\/s12016-014-8422-2","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"1591_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/MED.0b013e3283073a46","volume":"15","author":"D Zipris","year":"2008","unstructured":"Zipris D (2008) Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 15(4):326\u2013331. https:\/\/doi.org\/10.1097\/MED.0b013e3283073a46","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1591_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jaut.2013.06.001","volume":"44","author":"CB Myhr","year":"2013","unstructured":"Myhr CB, Hulme MA, Wasserfall CH et al (2013) The autoimmune disease-associated SNP rs917997 of IL18RAP controls IFNgamma production by PBMC. J Autoimmun 44:8\u201312. https:\/\/doi.org\/10.1016\/j.jaut.2013.06.001","journal-title":"J Autoimmun"},{"issue":"1","key":"1591_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12920-017-0243-8","volume":"10","author":"S Gao","year":"2017","unstructured":"Gao S, Wolanyk N, Chen Y, Jia S, Hessner MJ, Wang X (2017) Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes. BMC Med Genom 10(1):7. https:\/\/doi.org\/10.1186\/s12920-017-0243-8","journal-title":"BMC Med Genom"},{"issue":"1","key":"1591_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/cei.12834","volume":"186","author":"M Radenkovic","year":"2016","unstructured":"Radenkovic M, Silver C, Arvastsson J et al (2016) Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA). Clin Exp Immunol 186(1):46\u201356. https:\/\/doi.org\/10.1111\/cei.12834","journal-title":"Clin Exp Immunol"},{"key":"1591_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jaut.2015.08.012","volume":"66","author":"I Gomez-Tourino","year":"2016","unstructured":"Gomez-Tourino I, Arif S, Eichmann M, Peakman M (2016) T cells in type 1 diabetes: Instructors, regulators and effectors: a comprehensive review. J Autoimmun 66:7\u201316. https:\/\/doi.org\/10.1016\/j.jaut.2015.08.012","journal-title":"J Autoimmun"},{"issue":"1","key":"1591_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13287-017-0542-1","volume":"8","author":"L Ye","year":"2017","unstructured":"Ye L, Li L, Wan B et al (2017) Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus. Stem Cell Res Ther 8(1):90. https:\/\/doi.org\/10.1186\/s13287-017-0542-1","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"1591_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/s0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297. https:\/\/doi.org\/10.1016\/s0092-8674(04)00045-5","journal-title":"Cell"},{"issue":"4","key":"1591_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/dmrr.2719","volume":"32","author":"M Osmai","year":"2016","unstructured":"Osmai M, Osmai Y, Bang-Berthelsen CH et al (2016) MicroRNAs as regulators of beta-cell function and dysfunction. Diabetes Metab Res Rev 32(4):334\u2013349. https:\/\/doi.org\/10.1002\/dmrr.2719","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"1591_CR12","doi-asserted-by":"publisher","first-page":"e0142688","DOI":"10.1371\/journal.pone.0142688","volume":"10","author":"TA Fornari","year":"2015","unstructured":"Fornari TA, Donate PB, Assis AF et al (2015) Comprehensive survey of miRNA\u2013mRNA interactions reveals that Ccr7 and Cd247 (CD3 zeta) are posttranscriptionally controlled in pancreas infiltrating T lymphocytes of non-obese diabetic (NOD) mice. PLoS ONE 10(11):e0142688. https:\/\/doi.org\/10.1371\/journal.pone.0142688","journal-title":"PLoS ONE"},{"issue":"6","key":"1591_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/gene.2016.29","volume":"17","author":"VM De Jong","year":"2016","unstructured":"De Jong VM, Van der Slik AR, Laban S et al (2016) Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes. Genes Immun 17(6):342\u2013348. https:\/\/doi.org\/10.1038\/gene.2016.29","journal-title":"Genes Immun"},{"issue":"3","key":"1591_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbrc.2017.06.196","volume":"498","author":"G Wang","year":"2018","unstructured":"Wang G, Gu Y, Xu N, Zhang M, Yang T (2018) Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: association with ongoing islet autoimmunity. Biochem Biophys Res Commun 498(3):382\u2013387. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.196","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1591_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/emboj.2010.361","volume":"30","author":"T Melkman-Zehavi","year":"2011","unstructured":"Melkman-Zehavi T, Oren R, Kredo-Russo S et al (2011) miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors. EMBO J 30(5):835\u2013845. https:\/\/doi.org\/10.1038\/emboj.2010.361","journal-title":"EMBO J"},{"issue":"5","key":"1591_CR16","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.2337\/db12-0841","volume":"62","author":"MS Kanji","year":"2013","unstructured":"Kanji MS, Martin MG, Bhushan A (2013) Dicer1 is required to repress neuronal fate during endocrine cell maturation. Diabetes 62(5):1602\u20131611. https:\/\/doi.org\/10.2337\/db12-0841","journal-title":"Diabetes"},{"key":"1591_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1186\/1756-0500-6-491","volume":"6","author":"CV Collares","year":"2013","unstructured":"Collares CV, Evangelista AF, Xavier DJ et al (2013) Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes 6:491. https:\/\/doi.org\/10.1186\/1756-0500-6-491","journal-title":"BMC Res Notes"},{"key":"1591_CR18","doi-asserted-by":"publisher","unstructured":"Yang M, Ye L, Wang B et al (2015) Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients. J Diabetes 7(2):158\u2013165. https:\/\/doi.org\/10.1111\/1753-0407.12163","DOI":"10.1111\/1753-0407.12163"},{"key":"1591_CR19","doi-asserted-by":"publisher","first-page":"31479","DOI":"10.1038\/srep31479","volume":"6","author":"AA Seyhan","year":"2016","unstructured":"Seyhan AA, Nunez Lopez YO et al (2016) Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study. Sci Rep 6:31479. https:\/\/doi.org\/10.1038\/srep31479","journal-title":"Sci Rep"},{"issue":"1","key":"1591_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-016-0533-3","volume":"15","author":"Z He","year":"2016","unstructured":"He Z, Yi J, Liu X et al (2016) MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma. Mol Cancer 15(1):51. https:\/\/doi.org\/10.1186\/s12943-016-0533-3","journal-title":"Mol Cancer"},{"key":"1591_CR21","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.3389\/fimmu.2018.02711","volume":"9","author":"D Beuzelin","year":"2018","unstructured":"Beuzelin D, Kaeffer B (2018) Exosomes and miRNA-loaded biomimetic nanovehicles, a focus on their potentials preventing type-2 diabetes linked to metabolic syndrome. Front Immunol 9:2711. https:\/\/doi.org\/10.3389\/fimmu.2018.02711","journal-title":"Front Immunol"},{"key":"1591_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02062-0","author":"I Kokkinopoulou","year":"2019","unstructured":"Kokkinopoulou I, Maratou E, Mitrou P et al (2019) Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals. Endocrine. https:\/\/doi.org\/10.1007\/s12020-019-02062-0","journal-title":"Endocrine"},{"issue":"Suppl 2","key":"1591_CR23","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.2337\/diabetes.54.suppl_2.s68","volume":"54","author":"G Stenstrom","year":"2005","unstructured":"Stenstrom G, Gottsater A, Bakhtadze E, Berger B, Sundkvist G (2005) Latent autoimmune diabetes in adults: definition, prevalence, beta-cell function, and treatment. Diabetes 54(Suppl 2):S68\u201372. https:\/\/doi.org\/10.2337\/diabetes.54.suppl_2.s68","journal-title":"Diabetes"},{"key":"1591_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1196\/annals.1337.019","volume":"1037","author":"X Li","year":"2004","unstructured":"Li X, Zhou ZG, Huang G et al (2004) Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes. Ann N Y Acad Sci 1037:122\u2013126. https:\/\/doi.org\/10.1196\/annals.1337.019","journal-title":"Ann N Y Acad Sci"},{"key":"1591_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1196\/annals.1447.036","volume":"1150","author":"J Lin","year":"2008","unstructured":"Lin J, Zhou ZG, Wang JP, Zhang C, Huang G (2008) From Type 1, through LADA, to type 2 diabetes: a continuous spectrum? Ann N Y Acad Sci 1150:99\u2013102. https:\/\/doi.org\/10.1196\/annals.1447.036","journal-title":"Ann N Y Acad Sci"},{"issue":"19","key":"1591_CR26","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.3748\/wjg.v11.i19.2900","volume":"11","author":"L Yang","year":"2005","unstructured":"Yang L, Zhou ZG, Huang G, Ouyang LL, Li X, Yan X (2005) Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes. World J Gastroenterol 11(19):2900\u20132905. https:\/\/doi.org\/10.3748\/wjg.v11.i19.2900","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1591_CR27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.gene.2014.01.075","volume":"539","author":"P Takahashi","year":"2014","unstructured":"Takahashi P, Xavier DJ, Evangelista AF et al (2014) MicroRNA expression profiling and functional annotation analysis of their targets in patients with type 1 diabetes mellitus. Gene 539(2):213\u2013223. https:\/\/doi.org\/10.1016\/j.gene.2014.01.075","journal-title":"Gene"},{"key":"1591_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2019.03.008","volume":"490","author":"JD Massaro","year":"2019","unstructured":"Massaro JD, Polli CD, Costa ESM et al (2019) Post-transcriptional markers associated with clinical complications in TYPE 1 and type 2 diabetes mellitus. Mol Cell Endocrinol 490:1\u201314. https:\/\/doi.org\/10.1016\/j.mce.2019.03.008","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"1591_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3727\/096504017X15135941182107","volume":"26","author":"J Chen","year":"2018","unstructured":"Chen J, Chen X (2018) MYBL2 Is targeted by miR-143-3p and regulates breast cancer Cell proliferation and apoptosis. Oncol Res 26(6):913\u2013922. https:\/\/doi.org\/10.3727\/096504017X15135941182107","journal-title":"Oncol Res"},{"issue":"3","key":"1591_CR30","first-page":"866","volume":"10","author":"H Shi","year":"2018","unstructured":"Shi H, Shen H, Xu J, Zhao S, Yao S, Jiang N (2018) MiR-143-3p suppresses the progression of ovarian cancer. Am J Transl Res 10(3):866\u2013874","journal-title":"Am J Transl Res"},{"issue":"1","key":"1591_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41598-017-18739-3","volume":"8","author":"X Sun","year":"2018","unstructured":"Sun X, Dai G, Yu L, Hu Q, Chen J, Guo W (2018) miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep 8(1):606. https:\/\/doi.org\/10.1038\/s41598-017-18739-3","journal-title":"Sci Rep"},{"key":"1591_CR32","doi-asserted-by":"publisher","first-page":"9571","DOI":"10.1038\/srep09571","volume":"5","author":"W Wang","year":"2015","unstructured":"Wang W, Li R, Meng M et al (2015) MicroRNA profiling of CD3+ CD56+ cytokine-induced killer cells. Sci Rep 5:9571. https:\/\/doi.org\/10.1038\/srep09571","journal-title":"Sci Rep"},{"issue":"7","key":"1591_CR33","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.celrep.2018.04.038","volume":"23","author":"E Stelekati","year":"2018","unstructured":"Stelekati E, Chen Z, Manne S et al (2018) Long-term persistence of exhausted CD8 T cells in chronic infection is regulated by MicroRNA-155. Cell Rep 23(7):2142\u20132156. https:\/\/doi.org\/10.1016\/j.celrep.2018.04.038","journal-title":"Cell Rep"},{"issue":"1","key":"1591_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cei.12672","volume":"183","author":"LS Walker","year":"2016","unstructured":"Walker LS, von Herrath M (2016) CD4 T cell differentiation in type 1 diabetes. Clin Exp Immunol 183(1):16\u201329. https:\/\/doi.org\/10.1111\/cei.12672","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"1591_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11892-017-0900-5","volume":"17","author":"S Touch","year":"2017","unstructured":"Touch S, Clement K, Andre S (2017) T cell populations and functions are altered in human obesity and type 2 diabetes. Curr Diabetes Rep 17(9):81. https:\/\/doi.org\/10.1007\/s11892-017-0900-5","journal-title":"Curr Diabetes Rep"},{"issue":"7","key":"1591_CR36","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.4049\/jimmunol.1600476","volume":"198","author":"J Braune","year":"2017","unstructured":"Braune J, Weyer U, Hobusch C et al (2017) IL-6 Regulates M2 polarization and local proliferation of adipose tissue macrophages in obesity. J Immunol 198(7):2927\u20132934. https:\/\/doi.org\/10.4049\/jimmunol.1600476","journal-title":"J Immunol"},{"issue":"5","key":"1591_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/ni.2865","volume":"15","author":"J Mauer","year":"2014","unstructured":"Mauer J, Chaurasia B, Goldau J et al (2014) Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol 15(5):423\u2013430. https:\/\/doi.org\/10.1038\/ni.2865","journal-title":"Nat Immunol"},{"issue":"4","key":"1591_CR38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/dom.13595","volume":"21","author":"Y Xiang","year":"2018","unstructured":"Xiang Y, Huang G, Zhu Y et al (2018) Identification of autoimmune type 1 diabetes and multiple organ-specific autoantibodies in adult-onset non-insulin-requiring diabetes in China: a population-based multicentre nationwide survey. Diabetes Obes Metab 21(4):893\u2013902. https:\/\/doi.org\/10.1111\/dom.13595","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"1591_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/iub.1431","volume":"67","author":"ANA Moinuddin","year":"2015","unstructured":"Moinuddin ANA, Shahab U, Habeeb S, Ahmad S (2015) Immuno-chemistry of hydroxyl radical modified GAD-65: a possible role in experimental and human diabetes mellitus. IUBMB Life 67(10):746\u2013756. https:\/\/doi.org\/10.1002\/iub.1431","journal-title":"IUBMB Life"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01591-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-020-01591-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-020-01591-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:05:54Z","timestamp":1629417954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-020-01591-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s00592-020-01591-9","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"3 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee for Human Research, Central South University, approved this study. All the studies were conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}